Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study
about
The Obesity-Breast Cancer Conundrum: An Analysis of the IssuesWhy does obesity promote cancer? Epidemiology, biology, and open questionsRisk determination and prevention of breast cancerThe impact of overweight and obesity on breast cancer: data from Switzerland, so far a country little affected by the current global obesity epidemicMenopausal hormone therapy and breast cancer mortality: clinical implicationsMammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapiesAdiposity and cancer at major anatomical sites: umbrella review of the literatureDigoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis.Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years.Reproductive risk factors and breast cancer subtypes: a review of the literature.Pathogenesis, prevention, diagnosis and treatment of breast cancer.Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adultsEstrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational StudyBody size throughout adult life influences postmenopausal breast cancer risk among hispanic women: the breast cancer health disparities studyReproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort studyBody mass index associated with genome-wide methylation in breast tissue.Overall and central adiposity and breast cancer risk in the Sister StudyWeight and weight changes throughout life and postmenopausal breast cancer risk: a case-control study in FranceA multi-ethnic breast cancer case-control study in New Zealand: evidence of differential risk patternsPostmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women.Body size, modifying factors, and postmenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area Breast Cancer Study.Impact of body mass index on prognostically relevant breast cancer tumor characteristics.Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?Endogenous estradiol is not associated with poor physical health in postmenopausal breast cancer survivors.Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implicationsParity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening programInteractions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk.BMI, reproductive factors, and breast cancer molecular subtypes: A case-control study and meta-analysis.Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study.Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.Comparison of anthropometric measurements of adiposity in relation to cancer risk: a systematic review of prospective studies.Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.Central obesity and risks of pre- and postmenopausal breast cancer: a dose-response meta-analysis of prospective studies.Obesity and Breast Cancer.Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.Differential Patterns of Risk Factors for Early-Onset Breast Cancer by ER Status in African American Women.Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women.Anthropometric factors, physical activity, and breast cancer risk in relation to hormone receptor and menopausal status in Japanese women: a case-control study.Change in risk of breast cancer after receiving hormone replacement therapy by considering effect-modifiers: a systematic review and dose-response meta-analysis of prospective studies.
P2860
Q26747486-5496A0D2-FB41-4777-BDC0-34F956A73121Q26797301-87EA9943-9A96-46F7-B436-6AE5A0DC1916Q26991921-406D6C43-D8D7-427C-AEEF-5BFF6F6D19DBQ27021293-5DEA13CF-DC80-4C2B-B89C-1961A02140C4Q27022201-8AD019CF-3C48-4CF2-B36D-D69707ABC326Q28074177-5148439C-3E4A-4EBE-8371-5AF4A4D7DB26Q30235518-168A7742-25D1-4F32-A180-CDE8C7B55C37Q33566322-D8483514-1816-4481-A79B-C0DF70DE8BC3Q33578863-188A8833-85E3-41FA-BD50-275436907E24Q33632008-61D431F2-E471-41E2-86A5-3DFEB83569AEQ34023647-1A153711-7497-4880-AF2A-F303C7D173BBQ34041755-6648A46B-DFEA-4835-8035-2277FADC8329Q34336219-23C4CD8C-BEFC-4F87-9A30-D290634A0A12Q34972027-74FD84AF-1809-4EEC-BF36-ED539189765CQ35062955-62541799-AFD5-4BE6-87B4-BE8418D65276Q35760105-705BB5F3-57F4-4DDE-B2AD-D2C3DF5BB76EQ36117798-A673CE09-AC5C-495B-BA45-4CDFC77F7AE4Q36146921-5947524F-6355-4BCD-9267-77F0C1E142B5Q36484913-0252A202-0A8B-427F-8928-E34C9F3F4A1AQ36871025-8380EE41-B1B3-4A04-A30A-DFB2E03FF476Q36913430-D0811B8C-72A4-49F8-935F-FCE6FD4707F2Q37058003-8BAF1699-196A-4988-AD28-2FFEC0D65D56Q37203133-0B7628DB-9AE8-4CB2-B15D-A5BA238FF5D3Q37367134-27969B1C-A692-45BE-9BE0-2FF20063B265Q37525906-283BAAC9-8596-4D96-8C86-B168FCBBA1B2Q37602320-88645BFD-DB6E-41E8-8EB9-55774FA2D72DQ37679492-B0810296-E49C-407C-A829-C3B7E5B379D8Q37733409-116C46E2-CCCA-4345-99BA-5524A26037AAQ38106748-BC787496-22C3-4F05-A518-006E012FC57AQ38380655-0AB9B06F-16F4-4208-81E5-ED0CAF5717C9Q38627432-78B5C761-55ED-40E6-88A6-5BE63A53A5A9Q38694222-3E4BC597-CA01-4C21-A8BB-865D472398A5Q38750749-F8F8E8D9-DAA2-4188-BAFC-D4B56371AE8FQ38901717-27256B15-0A06-471F-B641-EE5B57C7AC53Q39026644-478D1044-B8B1-4EB3-9007-05CABB6EED2BQ39045823-31D949E6-D100-4D9C-BE2F-DD98669F0571Q40518502-A14C1427-99A7-4DB2-8B38-26741E1A45B4Q42457782-5EEC7081-80CC-4F0A-AB4B-5AE21654C969Q44018502-3D8648B5-1AEB-44BA-9DB7-01B097991EA0Q44074291-9F2C57AC-E238-478D-8AAB-22D43CD39F4F
P2860
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Adiposity, hormone replacement ...... large prospective cohort study
@ast
Adiposity, hormone replacement ...... large prospective cohort study
@en
type
label
Adiposity, hormone replacement ...... large prospective cohort study
@ast
Adiposity, hormone replacement ...... large prospective cohort study
@en
prefLabel
Adiposity, hormone replacement ...... large prospective cohort study
@ast
Adiposity, hormone replacement ...... large prospective cohort study
@en
P2093
P2860
P50
P356
P1476
Adiposity, hormone replacement ...... large prospective cohort study
@en
P2093
Birgit Teucher
Carla H van Gils
Franco Berrino
Inger Torhild Gram
Isabelle Romieu
José Ramón Quirós
Laure Dossus
Maria-José Sánchez
María-Dolores Chirlaque
Naomi E Allen
P2860
P2888
P356
10.1186/BCR3186
P50
P577
2012-05-14T00:00:00Z
P5875
P6179
1004997967